Hubid, Arnel .
HRN: 26-84-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/21/2025
03/28/2025
IVT
500 Mg
Q 8h
T/c Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes